8
Oct
2024

Qilu Pharmaceutical Co.Ltd

Exhibitor at CPHI Milan 2024 stand 16A18, Finished Dosage Formulations
About Us

Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, with a footprint in three segments: human medicines, veterinary medicines and crop protection products.

Qilu Pharmaceutical is dedicated to offering high-quality & trustworthy medicines to the world and improving people‘s well-being. 

Qilu Pharmaceutical develops, manufactures and distributes both finished formulations and active pharmaceutical ingredients.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 16A18, Finished Dosage Formulations

Products Featured at CPHI Milan 2024

  • Amikacin Sulfate

    Product Amikacin Sulfate

    Qilu Pharmaceutical Co., Ltd offers wide range of formulations which includes amikacin sulfate. Therapeutic category: anti-infective. Form: solution. Contact us for more information.
  • Aripiprazole

    Product Aripiprazole

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes aripiprazole. Therapeutic category: psychological. Contact us for more information.
  • Bortezomib

    Product Bortezomib

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes bortezomib. Therapeutic category: oncology. Contact us for more information.
  • Capecitabine

    Product Capecitabine

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes capecitabine. Therapeutic category: oncology. Contact us for more information.
  • Carboplatin

    Product Carboplatin

    Qilu Pharmaceutical Co., Ltd offers wide range of formulations which includes carboplatin. Therapeutic category: oncology. Form: injectable. Contact us for more information.